The Challenge of Intermediate-Risk Pulmonary Embolism

医学 肺栓塞 重症监护医学 心脏病学 内科学
作者
Spencer Weintraub,Joseph You,Sean R. Wilson,Andrew Galmer
出处
期刊:American Journal of Therapeutics [Lippincott Williams & Wilkins]
卷期号:30 (2): e134-e144 被引量:1
标识
DOI:10.1097/mjt.0000000000001605
摘要

Intermediate-risk pulmonary embolism is a common disease that is associated with significant morbidity and mortality; however, a standardized treatment protocol is not well-established.Treatments available for intermediate-risk pulmonary embolisms include anticoagulation, systemic thrombolytics, catheter-directed therapies, surgical embolectomy, and extracorporeal membrane oxygenation. Despite these options, there is no clear consensus on the optimal indication and timing of these interventions.Anticoagulation remains the cornerstone of treatment for pulmonary embolism; however, over the past 2 decades, there have been advances in the safety and efficacy of catheter-directed therapies. For massive pulmonary embolism, systemic thrombolytics and, sometimes, surgical thrombectomy are considered first-line treatments. Patients with intermediate-risk pulmonary embolism are at high risk of clinical deterioration; however, it is unclear whether anticoagulation alone is sufficient. The optimal treatment of intermediate-risk pulmonary embolism in the setting of hemodynamic stability with right heart strain present is not well-defined. Therapies such as catheter-directed thrombolysis and suction thrombectomy are being investigated given their potential to offload right ventricular strain. Several studies have recently evaluated catheter-directed thrombolysis and embolectomies and demonstrated the efficacy and safety of these interventions. Here, we review the literature on the management of intermediate-risk pulmonary embolisms and the evidence behind those interventions.There are many treatments available in the management of intermediate-risk pulmonary embolism. Although the current literature does not favor 1 treatment as superior, multiple studies have shown growing data to support catheter-directed therapies as potential options for these patients. Multidisciplinary pulmonary embolism response teams remain a key feature in improving the selection of advanced therapies and optimization of care.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李大明星发布了新的文献求助10
1秒前
天真苑睐完成签到,获得积分10
5秒前
lin完成签到,获得积分10
5秒前
ZDTT完成签到,获得积分10
6秒前
隐形曼青应助Berberin采纳,获得10
7秒前
香蕉觅云应助Asley采纳,获得10
7秒前
赘婿应助研友_8QyXr8采纳,获得20
10秒前
美女博士完成签到 ,获得积分10
10秒前
我爱吃肉发布了新的文献求助10
11秒前
梁雨发布了新的文献求助10
11秒前
12秒前
星辰大海应助小熊采纳,获得10
13秒前
zn完成签到,获得积分10
14秒前
14秒前
科研通AI6.2应助ss采纳,获得10
16秒前
轻舟轻舟完成签到,获得积分20
16秒前
17秒前
无私紫烟发布了新的文献求助10
17秒前
ffw1完成签到,获得积分10
17秒前
zzr发布了新的文献求助10
18秒前
21秒前
21秒前
稳重完成签到 ,获得积分10
21秒前
清爽秋荷发布了新的文献求助10
21秒前
22秒前
22秒前
ma完成签到,获得积分10
23秒前
l1zz应助盖世一侠采纳,获得10
24秒前
孟长歌完成签到,获得积分10
24秒前
大模型应助zengwr采纳,获得10
24秒前
ming发布了新的文献求助10
25秒前
26秒前
Asley发布了新的文献求助10
26秒前
qmmdfcc发布了新的文献求助10
26秒前
美女博士发布了新的文献求助10
26秒前
曾经尔岚发布了新的文献求助10
27秒前
30秒前
31秒前
鱼鱼鱼发布了新的文献求助10
31秒前
32秒前
高分求助中
Psychopathic Traits and Quality of Prison Life 1000
Malcolm Fraser : a biography 680
Signals, Systems, and Signal Processing 610
天津市智库成果选编 600
Forced degradation and stability indicating LC method for Letrozole: A stress testing guide 500
全相对论原子结构与含时波包动力学的理论研究--清华大学 500
A Foreign Missionary on the Long March: The Unpublished Memoirs of Arnolis Hayman of the China Inland Mission 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6452163
求助须知:如何正确求助?哪些是违规求助? 8264001
关于积分的说明 17610459
捐赠科研通 5517022
什么是DOI,文献DOI怎么找? 2903962
邀请新用户注册赠送积分活动 1880893
关于科研通互助平台的介绍 1722824